Cancer is often viewed as a caricature of normal developmental processes, but the extent to which its cellular heterogeneity truly recapitulates multilineage differentiation processes of normal tissues remains unknown. Here we implement single-cell PCR gene-expression analysis to dissect the cellular composition of primary human normal colon and colon cancer epithelia. We show that human colon cancer tissues contain distinct cell populations whose transcriptional identities mirror those of the different cellular lineages of normal colon. By creating monoclonal tumor xenografts from injection of a single (n = 1) cell, we demonstrate that the transcriptional diversity of cancer tissues is largely explained by in vivo multilineage differentiation and not only by
A r t i c l e s
The in vivo cellular composition of solid tissues is often difficult to investigate in a comprehensive and quantitative way. Techniques such as immunohistochemistry and flow cytometry are limited by the availability of antigen-specific monoclonal antibodies and by the small number of parallel measurements that can be performed on each individual cell. Traditional high-throughput assays, such as geneexpression arrays, when performed on whole tissues, provide information on average gene expression levels, and can be correlated only indirectly to quantitative modifications in cellular subpopulations. These limitations become particularly difficult to overcome when studying minority populations, such as stem cells, whose identification is made elusive by their low numbers and by the lack of exclusive markers. Moreover, in pathological states, such as cancer, it is usually impossible to determine whether perturbations in gene expression detected in whole tissues are due to modifications in the relative composition of different cell types or to aberrations in the gene-expression profile of mutated cells.
For example, although it has been postulated that multilineage differentiation can contribute to tumor heterogeneity [1] [2] [3] , this issue remains controversial 4 . Many in the field view cancer heterogeneity mainly as the result of clonal evolution secondary to genomic instability 5, 6 . Previous studies addressed this question, but could rely only on in vitro cultured cell lines and on simple morphological evidence [7] [8] [9] .
Moreover, recent evidence indicates that, in the absence of a molecular proof of monoclonal origin, results from in vitro experiments based on limiting dilution can be biased due to a dramatic increase in cell survival by cell hetero-doublets. This phenomenon is best exemplified in the case of the mouse small intestine, where growth and expansion of LGR5 + progenitor cells is dramatically enhanced by the presence of bystander epithelial feeder cells 10 . Based on these studies, it remained difficult to perform a quantitative measure of the degree of multilineage differentiation in cancer tissues and, above all, to investigate to what degree it actually translated into the differential activation of distinct transcriptional programs that would mirror and recapitulate the physiological processes observed in normal tissues. In this study we developed a method to dissect and investigate at the single-cell level the gene-expression profile of the distinct cell populations contained in primary human colon epithelia, both normal and neoplastic.
RESULTS

Description and technical validation of single-cell PCR
We combined fluorescence activated cell sorting (FACS) and singlecell PCR gene-expression analysis to perform a high-throughput transcriptional analysis of the distinct cellular populations contained in solid human tissues ( Supplementary Figs. 1 and 2 ). This method exploits the capacity of modern flow cytometers to sort single-cell dissection of transcriptional heterogeneity in human colon tumors Fig. 3 ), together with the use of microfluidic technologies to perform high-sensitivity multiplexed PCR from minute amounts of mRNA, thereby allowing parallel analysis of the expression of up to 96 genes for each individual cell. The large number of measurements per cell and the possibility to analyze several hundred cells in parallel from the same sample allow the use of statistical clustering algorithms to associate cells with similar gene expression profiles into well-defined subpopulations (Supplementary Fig. 2 ). Microfluidic platforms have been previously validated for single-cell gene-expression analysis [11] [12] [13] . Consistent with those results, our control experiments with titrated mRNA standards as well as single-cell experiments on a cell line validated the sensitivity of this approach for high-throughput analysis across multiple genes ( Supplementary Fig. 4 ).
Analysis of normal human colon epithelium
We first applied single-cell PCR to the study of normal human colon epithelial cells. Human colon epithelium is composed of heterogeneous populations of cells that express different protein markers based on their lineage, differentiation stage and functional status. Many of these cell subsets can be identified by immunohistochemistry against well-characterized markers, such as MUC2, expressed by goblet cells; MKI67, expressed by proliferating cells; KRT20 and CEACAM1 (also known as CD66a), preferentially expressed by cells at the top of the colonic crypt (Fig. 1a-d) 14 .
Under normal conditions, immature colon epithelial cells reside at the bottom of the colonic crypts (bottom-of-the-crypt cells) and express high levels of the surface marker CD44, whereas differentiated mature cells progressively migrate to the top (top-of-the-crypt cells) and progressively lose CD44 expression 14, 15 . We focused our analysis on the stem and progenitor cell compartments of the colonic epithelium by sorting the EpCAM high /CD44 + population ( Fig. 1e,f ; P12) which, in normal tissues, corresponds to the bottom of the human colonic crypt 14 . To study the more mature, terminally differentiated cell populations, we sorted and analyzed an equal number of cells from the EpCAM + /CD44 − /CD66a high population, which corresponds to the top of the human colonic crypt ( Fig. 1e,f; P11 ) 16 .
We first tested the ability of single-cell PCR gene-expression analysis to distinguish different cell populations using well-established reference markers. We analyzed and clustered colon epithelial cells using three genes encoding markers linked to either one of the two major cell lineages (that is, MUC2 for goblet cells and CA1 for enterocytes) or the immature compartment (that is, LGR5) of the colon epithelium 14, [17] [18] [19] . This experiment showed that genes encoding lineage-specific markers are frequently expressed in a mutually exclusive way, mirroring the expression pattern of corresponding proteins (Supplementary Fig. 5 ).
We then searched for gene-expression markers of the different cell populations, with a special focus on putative stem cell markers. We mined 1,568 publicly available gene-expression array data sets from human colon epithelia (Supplementary Table 1) , using a bioinformatics approach designed to identify developmentally regulated genes based on Boolean implication logic (Supplementary Fig. 6 ) 20 . The search yielded candidate genes whose expression was associated with that of other markers previously linked to individual colon epithelial cell lineages (Supplementary Figs. 7-9 ). Using an iterative approach, we screened >230 genes on eight independent samples of normal human colon epithelium by single-cell PCR gene-expression analysis. At each round, genes that were noninformative (that is, not differentially expressed in either positive or negative association with CA1, MUC2 or LGR5) were removed and replaced with new candidate genes. Thereby, we progressively built a list of 57 TaqMan assays that allowed us to analyze the expression  pattern of 53 distinct genes (3 housekeeping, 3 proliferation-related and  47 differentially expressed genes; Supplementary Table 2 ) with high robustness (Supplementary Fig. 10 ). This allowed us to characterize multiple cell populations, using both hierarchical clustering (Fig. 1g) and principal component analysis (PCA; Fig. 1h,i) .
Analysis of the EpCAM + /CD44 − /CD66a high population (enriched for top-of-the-crypt cells) revealed that this subset, although transcriptionally heterogeneous, was almost exclusively composed of cells expressing high levels of genes characteristic of mature enterocytes (e.g., CA1 + , CA2 + , KRT20 + , SLC26A3 + , AQP8 + and MS4A12 + ) 14, [21] [22] [23] and led to the discovery of at least two gene expression markers whose differential expression pattern-to our knowledge-has not been reported before (CD177 and GUCA2B) (Fig. 1g) . To validate the reliability of single-cell PCR gene-expression analysis results, we evaluated the distribution of SLC26A3 and CD177 protein expression in tissue sections and we confirmed its preferential expression at the top of the human colonic crypts (Supplementary Figs. 11 and 12 ).
We could also distinguish different subsets of cells with different transcriptional profiles within the EpCAM + /CD44 − /CD66a high population (e.g., CA1 + /SLC26A3 + versus GUCA2B + ). At the present time, it is not clear whether they represent distinct stages of differentiation or distinct functional subsets of colonic enterocytes. Nonetheless, their clearly unique transcriptional programs identify them as part of a distinct cellular population.
Analysis of the EpCAM high /CD44 + population (enriched for 'bottom-of-the-crypt' cells) revealed the presence of multiple populations, including: (i) a cell compartment characterized by the expression of genes linked to goblet cells (MUC2 + , TFF3 high , SPDEF + , SPINK4 + ) 24, 25 , (ii) a cell compartment characterized by the co-expression of genes associated with immature cells as well as genes known to be expressed by enterocytes (OLFM4 + , CA2 high ) and (iii) a cell compartment whose gene-expression profile mirrors that of a stem and/or progenitor cell compartment in the mouse small intestine (LGR5 + , ASCL2 + , PTPRO + , RGMB + ) 17, 26 . A synopsis of the key genes that define the gene-expression profile of the different populations is provided in Supplementary Table 3 .
The OLMF4 + /CA2 high and the LGR5 + /ASCL2 + compartments shared expression of several genes of functional interest in both stem cell and cancer biology, such as genes involved in self-renewal and chromatin remodeling (EZH2, BMI1) [27] [28] [29] , Wnt-pathway signaling (AXIN2) 30 , cell growth and chemotaxis (CXCL2) 31 , stem cell quiescence (LRIG1) 32 and oncogenes (MYC) 33 . The expression of proliferation markers, such as, MKI67, TOP2A, BIRC5 (also known as Survivin) appeared to be restricted to the EpCAM high /CD44 + (bottomof-the-crypt) population and particularly to the LGR5 + /ASCL2 + and MUC2 + /TFF3 high cells. This was partially expected based on both previously published data 14, 17, 19 and our own immunohistochemistry results (Supplementary Fig. 13c) .
We also observed that MUC2 + /TFF3 high cells were characterized by high expression levels of several genes of interest, including DLL1 and DLL4, encoding for two Notch ligands, and KRT20. The expression of KRT20 at the bottom of the crypt appears contrary to the notion of KRT20 as a terminal differentiation marker. However, a more careful examination of immunohistochemical stainings identified scattered KRT20 + cells, which can be morphologically identified as goblet cells (Supplementary Fig. 13a,b) . We also noticed that MUC2 + /TFF3 high cells, for the most part, did not express CFTR, the gene mutated in cystic fibrosis. The differential expression of DLL4 is of potential relevance to the clinical development of novel anti-tumor therapeutic agents directed against this molecule 34 .
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A r t i c l e s
Analysis of a primary human colon adenoma We then turned to cancer and investigated whether the cellular composition of the normal colonic epithelium is preserved in colorectal tumors, both benign and malignant. Fig. 2a-c ).
These observations were confirmed at the protein level by parallel immunohistochemical investigations for KRT20 and MUC2 (Fig. 2d,e) and are in agreement with the recent finding that LGR5 #2
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Analysis of a human colon cancer xenograft derived from a single cancer cell Tumor tissues, both benign and malignant, are known to undergo perturbations of normal differentiation processes, but it is unclear to what extent those perturbations reflect quantitative changes in cell composition or qualitative changes in gene-expression programs. This topic has historically been controversial [4] [5] [6] [7] [8] [9] 35 . Our own systematic study of KRT20 and MUC2 protein expression in human malignant colorectal cancer tissues, for instance, revealed that both markers are frequently expressed heterogeneously, in patterns that mirror those observed in normal colorectal epithelium (Supplementary Fig. 15 ). It remained unclear, however, to what extent cancer transcriptional heterogeneity is the result of clonal genetic heterogeneity 36 or epigenetic heterogeneity due to multilineage differentiation processes 9 .
To address this question from a functional perspective, we investigated whether a single (n = 1) human colorectal cancer cell can recreate the heterogeneous cell composition of parent tumor tissues, including the subpopulations that we discovered in this study. We injected NOD/ SCID/IL2Rγ −/− mice with single (n =1) EpCAM high /CD44 + cancer cells purified by flow cytometry from one of our well-characterized solid xenograft lines 37 , following infection with a lentivirus vector encoding enhanced green fluorescence protein (EGFP; Fig. 3a,b) .
Notably, the single cell-derived, lentivirus-tagged, EGFP + xenograft line generated in this experiment (UM-COLON#4 clone 8) closely reproduced the phenotypic diversity of its parent tumor both in terms of tissue histology (Figs. 2i,j and 3f,g ) and surface-marker phenotypic repertoire of cellular populations (Fig. 3c,d) . The line's monoclonal origin was confirmed by identification of a unique lentivirus integration site in all cancer cells (Fig. 3e) .
Tumorigenicity experiments done in NOD/SCID/IL2Rγ −/− mice revealed that, as observed in the parent tumors 37 , EGFP + /EpCAM high / CD44 + and EGFP + /EpCAM low /CD44 −/low cell populations were endowed with different tumorigenic capacity (Fig. 3h) . A single-cell PCR gene-expression analysis of the EpCAM high /CD44 + population from these monoclonal tumors demonstrated its heterogeneous lineage composition, showing the presence of three distinct compartments (that is, LGR5 + /ASCL2 + , OLFM4 + /CA2 high , MUC2 + /TFF3 high ), again characterized by distinctive gene signatures, closely mirroring those observed in corresponding immature populations of normal tissues (Fig. 2f-h) .
Taken together, these data formally prove that, in a subset of tumors, transcriptional heterogeneity is, at least partly, explained by multilineage differentiation processes that tend to recapitulate those observed in normal tissues.
Prognostic role of biomarkers identified by single-cell PCR To gain further insight into the potential functional implications of these observations, we compared the gene-expression pattern of genes associated with cell proliferation (that is, MKI67, TOP2A and BIRC5) in normal and cancer tissues. In this case too, we observed that the expression pattern observed in malignant tissues frequently mirrored that of normal ones.
Both in the normal tissue and in the monoclonal human colon cancer xenograft, for instance, all three proliferation markers were frequently expressed in a mutually exclusive way as compared to the differentiation marker KRT20 (Supplementary Fig. 16 ). This observation was subsequently confirmed at the protein level by a systematic study of MKI67 and KRT20 expression in serial sections from seven human colorectal cancer tissues, where MKI67 expression was often inversely associated with KRT20 ( Supplementary Fig. 17 ).
These observations suggest that, in at least some cases, bulk shortterm tumor growth is principally driven by a specific subset of the cancer cell population, characterized by a gene-expression repertoire characteristic of more immature cell compartments. This concept has important implications for the modeling of tumor growth kinetics Fig. 17 , samples SU87 and SU98, respectively). In accordance with our model, tumors characterized by the complete absence of KRT20 expression were very poorly differentiated and contained high percentages of MKI67 + cells (Supplementary Fig. 17, SU98) . We next tested whether these insights in the functional anatomy of the colon epithelium could have clinically useful applications. We evaluated whether quantitative expression levels of genes associated with differentiation processes could be used as a substitute measure for the cellular composition of the corresponding tumors and thereby serve to stratify colon cancer patients and predict clinical outcome. Our single-cell PCR gene-expression analysis data identified a set of sensitive and exclusive markers of top-ofthe-crypt CA1 + /SLC26A3 + cells (that is, CA1, MS4A12, CD177, SLC26A3). It also implicated KRT20 as a more promiscuous differentiation marker, whose expression is high in CA1 + /SLC26A3 + cells and a subset of MUC2 + /TFF3 high cells, is absent in LGR5 + /ASCL2 + cells, and is inversely associated with that of proliferation markers (MKI67, TOP2A, BIRC5). In addition, KRT20 expression can be easily detected by immunohistochemistry and is commonly used as a diagnostic marker in surgical pathology 38 , thus representing an attractive candidate for further clinical applications 39 .
Our first analysis of a pool of 1,568 independent human colon gene-expression arrays revealed that expression levels of genes characteristic for the CA1 + /SLC26A3 + cell population are strongly correlated (Supplementary Fig. 18) . The relationship between the expression of these top-of-the-crypt genes and KRT20 was described by a Boolean implication: tumors expressing high levels of top-of-the-crypt genes (top-crypt high ) were always KRT20 + , whereas tumors expressing low-to-negative levels of top-of-the-crypt genes (top-crypt −/low ) could be clearly separated into two groups: KRT20 + and KRT20 − (Supplementary Fig. 7) . Importantly, KRT20 − tumors expressed high levels of ALCAM/CD166 (Supplementary Fig. 19 ), a gene encoding for a surface marker characteristic of colon cancer cells with high tumorigenic potential in mouse xenotransplantation experiments 37 .
We developed software ('hierarchical exploration of gene expression microarrays on-line' , or Hegemon) to analyze the survival outcomes of human colon cancer patients after stratification into distinct gene-expression subsets, based on the expression of KRT20 and one of the marker genes of CA1 + /SLC26A3 + top-of-the-crypt cells (Fig. 4a-d Table 1 ). *P < 0.05, **P < 0.001. Age modeled as a continuous variable. HR, hazard ratio; CI, confidence interval; M, male; F, female.
A r t i c l e s between positive and negative expression, based on the StepMiner algorithm (Supplementary Fig. 20 ) 40 , and compared the clinical outcome of colon cancer patients in the three groups, using a pool of three independent data sets, containing 299 patients at different clinical stages (either AJCC stage I-IV or Dukes stage A-D) from the H. Lee Moffit Cancer Center, the Vanderbilt Medical Center and the Royal Melbourne Hospital 41, 42 , all of which were annotated with disease-free survival (DFS) data.
The three patient groups identified by these simple two-gene classifiers displayed substantially different clinical outcomes. An increasingly immature gene-expression profile corresponded to a progressively worse prognosis (Fig. 4e-h ). This result was independent of the gene chosen as marker of CA1 + /SLC26A3 + cells (that is, CA1, MS4A12, CD177, SLC26A3) and a multivariate analysis indicated that the prognostic value of the two-gene grouping system was not confounded by stage or other clinical variables (Fig. 4i-l) .
Tumors with a more immature gene-expression profile (group 3, KRT20 − /top-crypt −/low ) were more likely to be of high pathological grade (G3-G4; Supplementary Fig. 21 ) and of microsatellite instability status (MSI; Supplementary Fig. 22 ). These enrichments, however, did not confound the prognostic value of the two-gene classifier system, as the high hazard-ratios associated with more immature geneexpression groups remained statistically significant (P < 0.05), when tested against pathological grade in multivariate analysis (Table 1; with the exception of KRT20/CD177, P = 0.06), and because MSI + tumors are known to be usually associated with a better prognosis 43 . The prognostic effect of the two-gene classifier system was also independent of the recently described multigene EphB2 intestinal stem cell signature 19 , and was associated with comparable, if not superior, hazard ratios (Supplementary Fig. 23 ).
DISCUSSION
In this study, we implemented a method to investigate the cellular composition of solid tissues based on high-throughput parallel analysis of the gene-expression repertoire of single cells sorted by flow cytometry. We used this methodology to identify distinct cellular subsets of the human colon epithelium and to discover gene expression markers to define them. We then examined human colorectal tumors, both benign and malignant, and characterized them in terms of cell lineage composition and maturation. We showed that tumor tissues contain multiple cell types whose transcriptional identities mirror those of the cellular lineages of the normal epithelium. Moreover, we showed that tumor tissues generated from a single cell can recapitulate the lineage diversity of parent tumors, demonstrating that multilineage differentiation represents a key source of in vivo functional and phenotypic cancer cell heterogeneity.
Using these concepts as a guide, we identified biological subsets of human colorectal cancer, based on the expression of genes characteristic of specific cell types. These biological subsets were associated with substantially different clinical outcomes and could be identified by a simple two-gene classifier system. This prognostic scoring system appeared independent of and superior to pathological grading, which is, to this date, one of the few parameters incorporated into the design of therapeutic algorithms for colon cancer patients 44 . Owing to its simplicity and quantitative nature, this two-gene scoring system has the potential to move beyond the realm of purely experimental medicine and is a viable candidate for clinical applications.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturebiotechnology/.
Note: Supplementary information is available on the Nature Biotechnology website.
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The authors declare competing financial interests: details accompany the full-text HTML version of the paper at http://www.nature.com/nbt/index.html. ) and were maintained in RPMI-1640 medium, supplemented with 10% heat-inactivated fetal bovine serum, 2 mM l-glutamine, 120 µg/ml penicillin, 100 µg/ml streptomycin, 20 mM HEPES and 1 mM sodium pyruvate, as previously described 45 .
Solid tissue disaggregation. Solid tissues, normal and neoplastic, collected from primary surgical specimens or mouse xenografts, were mechanically and enzymatically disaggregated into single-cell suspensions, following previously published protocols 37 . Briefly, solid tissues were minced into small chunks (2 mm 3 ), rinsed with Hank's balanced salt solution (HBSS), finely chopped with a razor blade into minute fragments (0.2-0.5 mm 3 ), resuspended in serum-free RPMI-1640 medium (2 mM l-glutamine, 120 µg/ml penicillin, 100 µg/ml streptomycin, 50 µg/ml ceftazidime, 0.25 µg/ml amphotericin-B, 20 mM HEPES, 1 mM sodium pyruvate) together with 100 units/ml DNase-I and 200 units/ml Collagenase-III (Worthington) and incubated for 2 h at 37 °C to obtain enzymatic disaggregation. Cell suspensions were serially filtered with sterile gauze, 70-µm and 40-µm nylon meshes. Red blood cells were removed by osmotic lysis with ACK hypotonic buffer (150 mM NH 4 Cl, 1 mM KHCO 3 ; 5 min on ice).
Flow cytometry and single-cell sorting experiments.
To minimize loss of cell viability, we performed experiments on fresh cell suspensions, prepared shortly before flow cytometry 37 . Antibody staining was performed in HBSS supplemented with 2% heat-inactivated calf serum, 120 µg/ml penicillin, 100 µg/ml streptomycin, 50 µg/ml ceftazidime, 0.25 µg/ml amphotericin-B, 20 mM HEPES, 1 mM sodium pyruvate and 5 mM EDTA. Single-cell PCR. Single-cell gene-expression experiments were performed using Fluidigm's M96 quantitative PCR (qPCR) DynamicArray microfluidic chips (Fluidigm). Single cells were sorted by FACS into individual wells of 96-well PCR plates as described above. Each 96-well plate was preloaded with 5 µl/well of CellsDirect PCR mix (Invitrogen) and 0.1 µl/well (2 U) of SuperaseIn RNase-inhibitor. Following single-cell sorting, each well was supplemented with 1 µl (Applied Biosystems) of SuperScript-III RT/Platinum Taq (Invitrogen), 1.5 µl of Tris-EDTA (TE) buffer and 2.5 µl of a mixture of 96 pooled TaqMan assays (Applied Biosystems) containing each assay at 1:100 dilution. Single-cell mRNA was directly reverse transcribed into cDNA (50 °C for 15 min, 95 °C for 2 min), pre-amplified for 20 cycles (each cycle: 95 °C for 15 s, 60 °C for 4 min) and diluted 1:3 with TE buffer. A 2.25 µl aliquot of amplified cDNA was then mixed with 2.5 µl of TaqMan Universal PCR Master Mix (Applied Biosystems) and 0.25 µl of Fluidigm's "sample loading agent," then inserted into one of the chip "sample" inlets. Individual TaqMan assays were diluted at 1:1 ratios with TE. A 2.5 µl aliquot of each diluted TaqMan assay was mixed with 2.5 µl of Fluidigm's "assay loading agent" and individually inserted into one of the chip "assay" inlets. Samples and probes were loaded into M96 chips using an IFC Controller HX (Fluidigm), then transferred to a BioMark real-time PCR reader (Fluidigm) following manufacturer's instructions. A list of the 57 TaqMan assays used in this study is provided in Supplementary Table 2.
Analysis and graphic display of single-cell PCR data. Single-cell PCR data were analyzed and displayed using MATLAB (MathWorks) as summarized in Supplementary Figure 2. A minimum of 336 cells were analyzed for each phenotypic population, corresponding to four PCR plates, each containing 84 single cells (84 × 4 = 336), eight positive and four negative controls. As positive controls, we used replicates of a 1:1:1 mixture of total RNA standards from human normal colon (AM7986), human normal testes (AM7972) and HeLa cells (AM7852), all from Applied Biosystems. Results from cells not expressing ACTB (β-actin) and GAPDH (glyceraldehyde 3-phosphate dehydrogenase), or expressing them at extremely low values (Ct >35), were removed from the analysis. Gene-expression results were normalized by mean centering and dividing by 3 times the standard deviation (3 s.d.) of expressing cells (Supplementary Fig. 2) , and visualized using both hierarchical clustering and PCA 12, 46 . Hierarchical clustering was performed both on cells and genes, based on Euclidean or correlation distance metric and complete linkage. Positive or negative associations between two genes were tested by Spearman correlation, and P-values calculated based on 10,000 permutations. Both hierarchical clustering and PCA were based on the results for 47 differentially expressed genes (51 assays), and excluded results from housekeeping (ACTB, GAPDH, EpCAM) and proliferation-related genes (MKI67, TOP2A, BIRC) to avoid noise based on proliferation status. A detailed description of all these procedures is provided in the Supplementary Methods.
Immunohistochemistry and immunofluorescence. Paraffin-embedded tissue sections were stained with anti-human CK20 (clone Ks20.8, DakoCytomation), MUC2 (clone Ccp58, Fitzgerald Industries), MKI67 (clone MIB-1, DakoCytomation), CEACAM1/CD66a (clone 283340; R&D Systems) and SLC26A3 (lot no. R32905, Sigma Life Science) antibodies, according to manufacturers' instructions. Frozen tissue sections were stained with an anti-human CD177 antibody (clone MEM-166, BD Biosciences) followed by secondary staining with goat anti-mouse IgG-Alexa488 (Invitrogen). A description of immunohistochemistry and immunofluorescence protocols is provided in the Supplementary Methods. Generation and characterization of monoclonal tumors. EpCAM high /CD44 + human colon cancer cells were infected with the pLL3.7 lentivirus (Addgene #11795) 47 . Cells were infected by spin-inoculation for 4 h and injected in bulk
